Blood Targets of Adjuvant Drugs Against COVID19

Pierpaolo Di Micco1 Internal Medicine Department, Emergency Room Unit, Fatebenefratelli Hospital of Naples, Naples, ItalyCorrespondence[email protected]

Gianluca Di Micco2 Centro Diagnostico Varelli, Naples, Italy

Vincenzo Russo3 University Cardiology Clinic, Faculty of Medicine, Skopje, Macedonia

Maria Rita Poggiano1 Internal Medicine Department, Emergency Room Unit, Fatebenefratelli Hospital of Naples, Naples, Italy

Ciro Salzano1 Internal Medicine Department, Emergency Room Unit, Fatebenefratelli Hospital of Naples, Naples, Italy

Marijan Bosevski4 Department of Translational Medical Sciences, University of Campania “Luigi Vanvitelli” Monaldi Hospital, Naples80131, Italy

Michele Imparato1 Internal Medicine Department, Emergency Room Unit, Fatebenefratelli Hospital of Naples, Naples, Italy

Luca Fontanella1 Internal Medicine Department, Emergency Room Unit, Fatebenefratelli Hospital of Naples, Naples, Italy

Andrea Fontanella1 Internal Medicine Department, Emergency Room Unit, Fatebenefratelli Hospital of Naples, Naples, Italy

https://orcid.org/0000-0002-1279-8051

show all

Blood Targets of Adjuvant Drugs Against COVID19

Table 1 Reported Drugs Able to Interfere with SARS CoV2

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Blood Targets of Adjuvant Drugs Against COVID19

Figures & data

Table 1 Reported Drugs Able to Interfere with SARS CoV2

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date